Published in J Gen Virol on June 01, 2007
Viral control of mitochondrial apoptosis. PLoS Pathog (2008) 2.21
Structural and biochemical bases for the inhibition of autophagy and apoptosis by viral BCL-2 of murine gamma-herpesvirus 68. PLoS Pathog (2008) 2.09
The evolutionary conundrum of pathogen mimicry. Nat Rev Microbiol (2009) 1.87
Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses. Biochim Biophys Acta (2008) 1.82
Inhibition of IkappaB kinase by vaccinia virus virulence factor B14. PLoS Pathog (2008) 1.63
Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis. PLoS Pathog (2008) 1.57
Multiple functions of BCL-2 family proteins. Cold Spring Harb Perspect Biol (2013) 1.51
Activation of the PI3K/Akt pathway early during vaccinia and cowpox virus infections is required for both host survival and viral replication. J Virol (2009) 1.30
Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity. Front Oncol (2014) 1.29
TLR3 increases disease morbidity and mortality from vaccinia infection. J Immunol (2008) 1.26
Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA). PLoS One (2008) 1.23
Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7. PLoS Pathog (2011) 1.22
How vaccinia virus has evolved to subvert the host immune response. J Struct Biol (2011) 1.11
Poxvirus targeting of E3 ligase β-TrCP by molecular mimicry: a mechanism to inhibit NF-κB activation and promote immune evasion and virulence. PLoS Pathog (2013) 1.08
A poxvirus Bcl-2-like gene family involved in regulation of host immune response: sequence similarity and evolutionary history. Virol J (2010) 1.07
A survey of host range genes in poxvirus genomes. Infect Genet Evol (2012) 1.05
The immunoregulatory properties of oncolytic myxoma virus and their implications in therapeutics. Microbes Infect (2010) 1.03
Structural biology of the Bcl-2 family and its mimicry by viral proteins. Cell Death Dis (2013) 1.01
Vaccinia virus virulence factor N1L is a novel promising target for antiviral therapeutic intervention. J Med Chem (2010) 1.00
Inhibition of apoptosis and NF-κB activation by vaccinia protein N1 occur via distinct binding surfaces and make different contributions to virulence. PLoS Pathog (2011) 1.00
Vaccinia-induced epidermal growth factor receptor-MEK signalling and the anti-apoptotic protein F1L synergize to suppress cell death during infection. Cell Microbiol (2009) 0.98
Poxvirus proteomics and virus-host protein interactions. Microbiol Mol Biol Rev (2009) 0.98
MHC-I-restricted epitopes conserved among variola and other related orthopoxviruses are recognized by T cells 30 years after vaccination. Arch Virol (2008) 0.98
Vaccinia virus protein C4 inhibits NF-κB activation and promotes virus virulence. J Gen Virol (2012) 0.97
Mapping the IkappaB kinase beta (IKKbeta)-binding interface of the B14 protein, a vaccinia virus inhibitor of IKKbeta-mediated activation of nuclear factor kappaB. J Biol Chem (2011) 0.97
Vaccinia virus F1L protein promotes virulence by inhibiting inflammasome activation. Proc Natl Acad Sci U S A (2013) 0.97
Vaccinia protein F12 has structural similarity to kinesin light chain and contains a motor binding motif required for virion export. PLoS Pathog (2010) 0.97
Structures of the Shigella flexneri type 3 secretion system protein MxiC reveal conformational variability amongst homologues. J Mol Biol (2008) 0.96
Genetic screen of a mutant poxvirus library identifies an ankyrin repeat protein involved in blocking induction of avian type I interferon. J Virol (2013) 0.94
Phosphatidylserine receptors: enhancers of enveloped virus entry and infection. Virology (2014) 0.93
Molecular genetic analysis of orf virus: a poxvirus that has adapted to skin. Viruses (2015) 0.91
Increased ATP generation in the host cell is required for efficient vaccinia virus production. J Biomed Sci (2009) 0.90
Vaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence. J Gen Virol (2013) 0.90
The current status and future directions of myxoma virus, a master in immune evasion. Vet Res (2011) 0.90
The vaccinia virus O1 protein is required for sustained activation of extracellular signal-regulated kinase 1/2 and promotes viral virulence. J Virol (2011) 0.89
The fowlpox virus BCL-2 homologue, FPV039, interacts with activated Bax and a discrete subset of BH3-only proteins to inhibit apoptosis. J Virol (2009) 0.89
Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence. J Gen Virol (2008) 0.89
A mechanism for the inhibition of DNA-PK-mediated DNA sensing by a virus. PLoS Pathog (2013) 0.88
Vaccinia virus lacking the Bcl-2-like protein N1 induces a stronger natural killer cell response to infection. J Gen Virol (2008) 0.86
Vaccinia virus protein K7 is a virulence factor that alters the acute immune response to infection. J Gen Virol (2013) 0.86
Deerpox virus encodes an inhibitor of apoptosis that regulates Bak and Bax. J Virol (2010) 0.86
Vaccinia virus inhibits NF-κB-dependent gene expression downstream of p65 translocation. J Virol (2013) 0.85
The vaccinia virus-encoded Bcl-2 homologues do not act as direct Bax inhibitors. J Virol (2011) 0.84
Robust intrapulmonary CD8 T cell responses and protection with an attenuated N1L deleted vaccinia virus. PLoS One (2008) 0.84
Vaccinia virus protein A49 is an unexpected member of the B-cell Lymphoma (Bcl)-2 protein family. J Biol Chem (2015) 0.83
Deletion of the vaccinia virus N2L gene encoding an inhibitor of IRF3 improves the immunogenicity of modified vaccinia virus Ankara expressing HIV-1 antigens. J Virol (2014) 0.83
Structural determinants of caspase-9 inhibition by the vaccinia virus protein, F1L. J Biol Chem (2011) 0.83
Characterization and structure of the vaccinia virus NF-κB antagonist A46. J Biol Chem (2013) 0.82
Innate immune response of human plasmacytoid dendritic cells to poxvirus infection is subverted by vaccinia E3 via its Z-DNA/RNA binding domain. PLoS One (2012) 0.82
Sheeppox virus SPPV14 encodes a Bcl-2-like cell death inhibitor that counters a distinct set of mammalian proapoptotic proteins. J Virol (2012) 0.82
A179L, a viral Bcl-2 homologue, targets the core Bcl-2 apoptotic machinery and its upstream BH3 activators with selective binding restrictions for Bid and Noxa. Virology (2008) 0.82
Structural insight into BH3 domain binding of vaccinia virus antiapoptotic F1L. J Virol (2014) 0.81
A vaccinia virus deletion mutant reveals the presence of additional inhibitors of NF-kappaB. J Virol (2010) 0.80
Genetic screen of a library of chimeric poxviruses identifies an ankyrin repeat protein involved in resistance to the avian type I interferon response. J Virol (2013) 0.80
N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection. J Virol (2011) 0.80
Structural insight into African Swine Fever virus A179L mediated inhibition of apoptosis. J Virol (2017) 0.78
Variola virus F1L is a Bcl-2-like protein that unlike its vaccinia virus counterpart inhibits apoptosis independent of Bim. Cell Death Dis (2015) 0.78
The vaccinia virus K7 protein promotes histone methylation associated with heterochromatin formation. PLoS One (2017) 0.77
Enhancement of CD8(+) T-cell memory by removal of a vaccinia virus nuclear factor-κB inhibitor. Immunology (2015) 0.77
Inhibition of Translation Initiation by Protein 169: A Vaccinia Virus Strategy to Suppress Innate and Adaptive Immunity and Alter Virus Virulence. PLoS Pathog (2015) 0.77
Deletion of Fifteen Open Reading Frames from Modified Vaccinia Virus Ankara Fails to Improve Immunogenicity. PLoS One (2015) 0.77
Pivotal role of RIP1 and MLKL in neuronal cell death induced by the human neuroinvasive coronavirus OC43. J Virol (2016) 0.77
Analysis of the anti-apoptotic activity of four vaccinia virus proteins demonstrates that B13 is the most potent inhibitor in isolation and during viral infection. J Gen Virol (2014) 0.77
Vaccinia virus virulence factor N1 can be ubiquitylated on multiple lysine residues. J Gen Virol (2014) 0.76
Structure of vaccinia virus A46, an inhibitor of TLR4 signaling pathway, shows the conformation of VIPER motif. Protein Sci (2014) 0.76
Attenuated and replication-competent vaccinia virus strains M65 and M101 with distinct biology and immunogenicity as potential vaccine candidates against pathogens. J Virol (2013) 0.76
The N Terminus of the Vaccinia Virus Protein F1L Is an Intrinsically Unstructured Region That Is Not Involved in Apoptosis Regulation. J Biol Chem (2016) 0.76
Vaccinia Virus Protein C6 Inhibits Type I IFN Signalling in the Nucleus and Binds to the Transactivation Domain of STAT2. PLoS Pathog (2016) 0.75
Dual function of the pUL7-pUL51 tegument protein complex in HSV-1 infection. J Virol (2016) 0.75
Molecular network, pathway, and functional analysis of time-dependent gene changes associated with pancreatic cancer susceptibility to oncolytic vaccinia virotherapy. Mol Ther Oncolytics (2016) 0.75
Attenuation of Vaccinia Virus. Acta Naturae (2016) 0.75
Vaccinia Virus Immunomodulator A46: A Lipid and Protein-Binding Scaffold for Sequestering Host TIR-Domain Proteins. PLoS Pathog (2016) 0.75
Increased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulators. Vaccine (2016) 0.75
Multiple Bcl-2 family immunomodulators from vaccinia virus regulate MAPK/AP-1 activation. J Gen Virol (2016) 0.75
Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01
Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28
A simple method for displaying the hydropathic character of a protein. J Mol Biol (1982) 150.65
Maximum-likelihood density modification. Acta Crystallogr D Biol Crystallogr (2000) 20.67
Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell (2005) 20.30
MOLPROBITY: structure validation and all-atom contact analysis for nucleic acids and their complexes. Nucleic Acids Res (2004) 9.86
Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science (1997) 9.73
X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature (1996) 8.37
Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol (1997) 7.71
The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene (2003) 7.41
Structure of Bax: coregulation of dimer formation and intracellular localization. Cell (2000) 7.00
Poxviruses and immune evasion. Annu Rev Immunol (2001) 4.80
Viruses and apoptosis. Annu Rev Microbiol (1999) 4.24
Crystal structure of cat muscle pyruvate kinase at a resolution of 2.6 A. J Mol Biol (1979) 3.88
A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Commun (1993) 3.79
A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization. Acta Crystallogr D Biol Crystallogr (2005) 3.75
Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol (2001) 3.63
Structural biology of the Bcl-2 family of proteins. Biochim Biophys Acta (2004) 3.47
The structure of a Bcl-xL/Bim fragment complex: implications for Bim function. Immunity (2003) 3.19
Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies. Protein Sci (2000) 3.00
Bcl-2 decreases the free Ca2+ concentration within the endoplasmic reticulum. Proc Natl Acad Sci U S A (2000) 2.87
Phosphorylation of BCL-2 regulates ER Ca2+ homeostasis and apoptosis. EMBO J (2004) 2.77
Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nat Med (1997) 2.64
Solution structure of the antiapoptotic protein bcl-2. Proc Natl Acad Sci U S A (2001) 2.60
Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell (1999) 2.58
The genome of fowlpox virus. J Virol (2000) 2.30
Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors. J Biol Chem (2004) 2.21
Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands. J Biol Chem (2004) 2.12
An African swine fever virus gene with similarity to the proto-oncogene bcl-2 and the Epstein-Barr virus gene BHRF1. J Virol (1993) 1.83
The structure of Bcl-w reveals a role for the C-terminal residues in modulating biological activity. EMBO J (2003) 1.59
Mapping and insertional mutagenesis of a vaccinia virus gene encoding a 13,800-Da secreted protein. Virology (1989) 1.57
The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence. J Gen Virol (2002) 1.57
The genome of canarypox virus. J Virol (2004) 1.56
Solution structure of a Bcl-2 homolog from Kaposi sarcoma virus. Proc Natl Acad Sci U S A (2002) 1.52
Vaccinia virus N1L protein resembles a B cell lymphoma-2 (Bcl-2) family protein. Protein Sci (2006) 1.45
Evasion of innate immunity by vaccinia virus. Parasitology (2005) 1.42
The genome of turkey herpesvirus. J Virol (2001) 1.42
The vaccinia virus F1L protein interacts with the proapoptotic protein Bak and inhibits Bak activation. J Virol (2005) 1.34
A surface groove essential for viral Bcl-2 function during chronic infection in vivo. PLoS Pathog (2005) 1.30
BCL-XL dimerization by three-dimensional domain swapping. J Mol Biol (2005) 1.28
Near death experiences: poxvirus regulation of apoptotic death. Virology (2006) 1.27
Solution structure of the BHRF1 protein from Epstein-Barr virus, a homolog of human Bcl-2. J Mol Biol (2003) 1.26
Interaction of F1L with the BH3 domain of Bak is responsible for inhibiting vaccinia-induced apoptosis. Cell Death Differ (2006) 1.20
Viral Bcl-2 homologs and their role in virus replication and associated diseases. Biochim Biophys Acta (2004) 1.14
Modified vaccinia virus Ankara protein F1L is a novel BH3-domain-binding protein and acts together with the early viral protein E3L to block virus-associated apoptosis. Cell Death Differ (2006) 1.11
Ultrastructural localization of BHRF1: an Epstein-Barr virus gene product which has homology with bcl-2. Cancer Res (1994) 0.96
Time-course induction of apoptosis by wild-type and attenuated strains of rubella virus. J Gen Virol (2003) 0.81
Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J Virol (2006) 6.30
Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med (2006) 5.90
Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. Nat Med (2003) 4.64
Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest (2008) 4.30
Protein production and purification. Nat Methods (2008) 3.97
Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL. Nature (2002) 3.78
A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization. Acta Crystallogr D Biol Crystallogr (2005) 3.75
IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med (2014) 3.32
A versatile ligation-independent cloning method suitable for high-throughput expression screening applications. Nucleic Acids Res (2007) 3.22
A structural basis for immunodominant human T cell receptor recognition. Nat Immunol (2003) 3.15
Lysine methylation as a routine rescue strategy for protein crystallization. Structure (2006) 3.14
Towards rationalization of crystallization screening for small- to medium-sized academic laboratories: the PACT/JCSG+ strategy. Acta Crystallogr D Biol Crystallogr (2005) 3.13
What does structure tell us about virus evolution? Curr Opin Struct Biol (2005) 3.02
The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J Exp Med (2003) 2.85
A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat Struct Mol Biol (2012) 2.81
Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J Exp Med (2005) 2.66
Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2. Nat Struct Mol Biol (2008) 2.58
Insights into assembly from structural analysis of bacteriophage PRD1. Nature (2004) 2.47
Crystal structure of a soluble CD28-Fab complex. Nat Immunol (2005) 2.46
The interaction properties of costimulatory molecules revisited. Immunity (2002) 2.43
A mechanical explanation of RNA pseudoknot function in programmed ribosomal frameshifting. Nature (2006) 2.41
Bluetongue virus VP4 is an RNA-capping assembly line. Nat Struct Mol Biol (2007) 2.40
Poxvirus genomes: a phylogenetic analysis. J Gen Virol (2004) 2.40
Glycoprotein structural genomics: solving the glycosylation problem. Structure (2007) 2.40
A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol (2002) 2.31
Unravelling the dynamics of RNA degradation by ribonuclease II and its RNA-bound complex. Nature (2006) 2.31
Detection of a fourth orbivirus non-structural protein. PLoS One (2011) 2.11
The postfusion structure of baculovirus gp64 supports a unified view of viral fusion machines. Nat Struct Mol Biol (2008) 2.09
Structure of the integrin binding fragment from fibrillin-1 gives new insights into microfibril organization. Structure (2004) 1.97
The structure of an RNAi polymerase links RNA silencing and transcription. PLoS Biol (2006) 1.96
In situ macromolecular crystallography using microbeams. Acta Crystallogr D Biol Crystallogr (2012) 1.94
Structure and functionality in flavivirus NS-proteins: perspectives for drug design. Antiviral Res (2009) 1.87
Insights into the evolution of a complex virus from the crystal structure of vaccinia virus D13. Structure (2011) 1.86
Atomic snapshots of an RNA packaging motor reveal conformational changes linking ATP hydrolysis to RNA translocation. Cell (2004) 1.86
Genome sequence diversity and clues to the evolution of variola (smallpox) virus. Science (2006) 1.84
Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoS Pathog (2010) 1.82
Endocytic tubules regulated by Rab GTPases 5 and 11 are used for envelopment of herpes simplex virus. EMBO J (2012) 1.75
Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease. Pharmacol Ther (2008) 1.74
Vaccinia virus morphogenesis and dissemination. Trends Microbiol (2008) 1.73
Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans. J Gen Virol (2005) 1.70
Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47. Mol Cell (2008) 1.68
The ligand-binding face of the semaphorins revealed by the high-resolution crystal structure of SEMA4D. Nat Struct Biol (2003) 1.68
Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination. Nat Med (2006) 1.64
Inhibition of IkappaB kinase by vaccinia virus virulence factor B14. PLoS Pathog (2008) 1.63
An in-depth analysis of original antigenic sin in dengue virus infection. J Virol (2010) 1.63
Ligand-induced and nonfusogenic dissolution of a viral membrane. Proc Natl Acad Sci U S A (2006) 1.62
Antibody-sensitive and antibody-resistant cell-to-cell spread by vaccinia virus: role of the A33R protein in antibody-resistant spread. J Gen Virol (2002) 1.59
Mechanism of membranous tunnelling nanotube formation in viral genome delivery. PLoS Biol (2013) 1.58
Structure unifies the viral universe. Annu Rev Biochem (2012) 1.58
Picornavirus uncoating intermediate captured in atomic detail. Nat Commun (2013) 1.57
Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis. PLoS Pathog (2008) 1.57
The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence. J Gen Virol (2002) 1.57
The nsp9 replicase protein of SARS-coronavirus, structure and functional insights. Structure (2004) 1.55
Membrane structure and interactions with protein and DNA in bacteriophage PRD1. Nature (2004) 1.53
DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. Elife (2012) 1.53
Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model. J Gen Virol (2005) 1.52
Implications of the HIV-1 Rev dimer structure at 3.2 A resolution for multimeric binding to the Rev response element. Proc Natl Acad Sci U S A (2010) 1.51
Evolution of viral structure. Theor Popul Biol (2002) 1.48
How baculovirus polyhedra fit square pegs into round holes to robustly package viruses. EMBO J (2009) 1.46
The Protein Information Management System (PiMS): a generic tool for any structural biology research laboratory. Acta Crystallogr D Biol Crystallogr (2011) 1.45
An investigation of the therapeutic value of vaccinia-immune IgG in a mouse pneumonia model. J Gen Virol (2005) 1.45
A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection. J Gen Virol (2003) 1.43
The vaccinia virus F12L protein is associated with intracellular enveloped virus particles and is required for their egress to the cell surface. J Gen Virol (2002) 1.38
Insights into virus evolution and membrane biogenesis from the structure of the marine lipid-containing bacteriophage PM2. Mol Cell (2008) 1.37
Evolution of complex RNA polymerases: the complete archaeal RNA polymerase structure. PLoS Biol (2009) 1.36
Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes. J Gen Virol (2002) 1.36
Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity. J Virol (2003) 1.34
The sequence of camelpox virus shows it is most closely related to variola virus, the cause of smallpox. J Gen Virol (2002) 1.33
Vaccinia virus cores are transported on microtubules. J Gen Virol (2003) 1.33
Crystal structure and carbohydrate analysis of Nipah virus attachment glycoprotein: a template for antiviral and vaccine design. J Virol (2008) 1.32
Structure and binding kinetics of three different human CD1d-alpha-galactosylceramide-specific T cell receptors. J Exp Med (2006) 1.32
Outrunning free radicals in room-temperature macromolecular crystallography. Acta Crystallogr D Biol Crystallogr (2012) 1.32